Related Experiment Video

Updated: Aug 9, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

[Levels of various components of the classical and alternative pathways of complement activation in diabetes mellitus

L P Titov, G V Korvigo, G D Kharitonik

    Problemy Endokrinologii
    |March 1, 1987
    PubMed

    Insights

    Complement system alterations are observed in both insulin-dependent and non-insulin-dependent diabetes. These changes in complement components C3, C4, C5, factor B, and factor D may reflect disease pathogenesis.

    Area of Science:

    • Immunology
    • Endocrinology
    • Biochemistry

    Context:

    • Diabetes mellitus is a complex metabolic disorder.
    • The complement system plays a crucial role in innate immunity.
    • Dysregulation of the complement system is implicated in various diseases.

    Purpose:

    • To investigate the state of the complement system in patients with insulin-dependent diabetes mellitus (IDDM) and non-insulin-dependent diabetes mellitus (NIDDM).
    • To analyze complement component levels (C2, C4, C3, C5, factor B, factor D) in diabetic patients compared to healthy controls.
    • To examine the association between HLA antigens (B8, B18) and complement levels in IDDM.

    Summary:

    • Elevated levels of C3, C4, factor B, and factor D were found in IDDM patients compared to controls.
    • NIDDM patients showed increased C4, factor B, and factor D, but decreased C5 levels.
    • In IDDM patients with HLA-B18, C3 was elevated, while C4, factor B, and factor D were lower than in other diabetic patients.
    • Diabetic nephropathy was associated with decreased C3 and C5, and increased C4 levels.

    Impact:

    • The study reveals significant variations in complement system components in diabetic patients.
    • These findings suggest that complement system dysregulation is a feature of diabetes pathogenesis.
    • Further research can explore therapeutic strategies targeting the complement system in diabetes management.

    More Related Videos

    Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States07:09

    Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

    Published on: April 1, 2015

    Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature05:54

    Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature

    Published on: January 24, 2025

    Related Concept Videos

    Complement System01:27

    Complement System

    The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
    Pathophysiology of Diabetes01:20

    Pathophysiology of Diabetes

    Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
    Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
    Diabetes Mellitus: Introduction01:26

    Diabetes Mellitus: Introduction

    Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
    Type I Diabetes II: Pathophysiology01:26

    Type I Diabetes II: Pathophysiology

    Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
    Type II Diabetes II: Pathophysiology01:24

    Type II Diabetes II: Pathophysiology

    PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
    Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

    Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

    Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...